Mounjaro vs Wegovy: UK Clinical Comparison (2026)
How Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4mg) differ in mechanism, indication, dose schedule and side-effect profile. UK patient information, no prescription-medicine prices.
Quick answer
Updated May 2026Mounjaro prices in the UK vary by dose, provider and what is included in the consultation or monitoring package. Higher maintenance doses can cost more than starter-dose offers.
- Compare dose-by-dose prices, not only the lower-cost starting dose.
- Check whether consultation, delivery and clinical support are included.
- Use NHS eligibility tools separately from private price comparison.
UK weight loss cost summary
| Treatment | Typical cost structure | Watch out for |
|---|---|---|
| Mounjaro | Monthly medication plus consultation or prescription fees | Higher maintenance doses can cost more |
| Wegovy | Monthly medication plus consultation or prescription fees | Starter offers may not reflect long-term cost |
| Ozempic | Monthly medication plus consultation or prescription fees | Usually diabetes-licensed, so weight-loss prescribing rules matter |
Sources and updates
How this page is sourced
Sources
- Published provider price pages
- GPhC and CQC public registers where relevant
- Provider inclusion and monitoring information
- TreatCompare compiled pricing dataset
Methodology: We compare advertised provider prices and what is visibly included, such as consultation, prescription, delivery and monitoring. Prices can change and may vary by dose.
Caveat: This page is for cost comparison and planning. It is not medical advice.
Important context
Healthcare prices can change without notice and may exclude consultation fees, medication, diagnostics, anaesthetic, facility fees, follow-up care or add-ons. TreatCompare summarises published or compiled pricing for comparison and planning only. Always verify the current total directly before paying.
- Source type
- TreatCompare compiled research
- Primary source
- Provider-published information and TreatCompare research
- Reporting period
- 2026-05-12
- Last updated
- 2026-05-12
- Figure type
- Mixed sources
- Use
- Research and comparison only
Are you a clinic, provider or data owner?
If you believe information on this page is inaccurate, out of date, incomplete or presented without necessary context, contact us with the page URL and supporting evidence. We review correction requests promptly, but they are not automatically accepted.
UK comparison next step
Compare real monthly costs before choosing a provider
- Medication price can change by dose.
- Consultation and prescription fees may be separate.
- Ongoing monthly cost matters more than headline starter price.
Cost FAQs
How much does Mounjaro cost in the UK?
Mounjaro cost depends on dose and provider. Compare the current monthly price and whether consultation, prescription, delivery and monitoring are included.
Why does Mounjaro get more expensive by dose?
Some providers charge more for higher maintenance doses. Starter-dose offers can look lower-cost than the likely ongoing monthly cost.
Is consultation included in UK weight-loss injection prices?
Sometimes. Some providers include consultation and prescribing in the headline price, while others charge separately or bundle support differently.
Can I switch provider to reduce cost?
You may be able to compare and switch providers, but the new provider will still need to run its own eligibility and safety checks before prescribing.
What is the best way to compare UK GLP-1 prices?
Compare dose-by-dose monthly cost, consultation fees, delivery, monitoring and provider registration. Do not rely only on the lowest starter price.
How this guide was checked
TreatCompare uses published provider fees, official regulator registers, NHS/PBS/Medicare references where relevant, and the methodology described on our methodology page. If a clinic, provider or reader spots information that is out of date, they can use our corrections page. Prices are point-in-time and can change before booking.
Most useful next step
Compare current Weight Loss options
This guide explains the costs. The live comparison pages show the current prices, providers and next actions.
Continue from this guide
Turn this Weight Loss article into a comparison
Article visitors often need one of three routes next: provider prices, a calculator, or a related guide that narrows the decision.
Compare next
Compare UK Mounjaro prices, dose costs, provider checks and NHS eligibility.
Important information for UK consumers. Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4mg) are prescription-only medicines (POMs) in the UK. UK regulations restrict the advertising of prescription medicines to the public, so this article is a clinical comparison for patient information — it is not an advertisement, not an offer of sale, and not medical advice. This article does not display UK prices.
In short
Mechanism
| Aspect | Mounjaro (tirzepatide) | Wegovy (semaglutide 2.4mg) |
|---|---|---|
| Class | Dual GIP / GLP-1 receptor agonist | GLP-1 receptor agonist |
| Manufacturer | Eli Lilly | Novo Nordisk |
| Administration | Once-weekly subcutaneous injection (KwikPen) | Once-weekly subcutaneous injection (FlexTouch pen) |
| UK indication | Weight management in eligible adults; separately licensed for type 2 diabetes | Weight management in eligible adults |
| NICE technology appraisal | TA1026 | TA875 |
Dose escalation
Both medicines use a stepped dose-escalation schedule under prescriber guidance, designed to manage gastrointestinal tolerability:
| Step | Mounjaro | Wegovy |
|---|---|---|
| Start | 2.5mg weekly | 0.25mg weekly |
| Increments | 5mg → 7.5mg → 10mg → 12.5mg → 15mg | 0.5mg → 1mg → 1.7mg → 2.4mg |
| Typical escalation | Several months | Around 16 weeks |
| Maintenance | Up to 15mg weekly (clinical decision) | 2.4mg weekly |
Side-effect profile
Both medicines share a broadly similar side-effect profile, dominated by gastrointestinal effects during dose escalation. The MHRA Drug Safety Update on GLP-1 receptor agonists is the authoritative UK pharmacovigilance source.
| Effect | Mounjaro | Wegovy |
|---|---|---|
| Nausea | Common, particularly at escalation | Common, particularly at escalation |
| Vomiting | Common | Common |
| Diarrhoea | Common | Common |
| Constipation | Common | Common |
| Injection-site reactions | Common | Common |
| Pancreatitis (rare) | Reported | Reported |
| Gallbladder events | Reported | Reported |
See the MHRA Yellow Card side-effects data page for UK real-world reporting summaries.
Healthcare data note
Sources, review and limits
Main sources
- TreatCompare compiled research and provider-published information
Methodology: This article is a clinical comparison of the two medicines for UK patient information. It describes mechanism, dose escalation, side-effect profile and NHS access framework. It does not display UK private prices, recommend either medicine, or replace prescriber assessment. Trial endpoints quoted are population averages from pivotal trials; individual response varies. The UK Human Medicines Regulations 2012 prohibit advertising prescription-only medicines to the public, so price comparisons are not included.
NHS access
Both medicines are recommended by NICE for weight management in eligible adults under separate technology appraisals. NHS rollout is staged by cohort and decided by NHS England commissioning policy. Use the NHS eligibility checker.
What to discuss with a UK prescriber
- Which medicine is more appropriate for your circumstances, based on indication and clinical profile.
- The dose escalation schedule and tolerability monitoring approach.
- Common and serious side effects, and what to do if they occur.
- Whether NHS-funded treatment is realistic, and the practical timing.
- The follow-up review schedule and ongoing monitoring requirements.
If you have spotted an error
Please tell us via the corrections route.
UK comparison next step
Compare real monthly costs before choosing a provider
- Medication price can change by dose.
- Consultation and prescription fees may be separate.
- Ongoing monthly cost matters more than headline starter price.
Frequently asked questions
What is the difference between Mounjaro and Wegovy?
Both are once-weekly subcutaneous injections for weight management in adults who meet the indication. Mounjaro contains tirzepatide and is a dual GIP/GLP-1 receptor agonist (Eli Lilly). Wegovy contains semaglutide 2.4mg and is a GLP-1 receptor agonist (Novo Nordisk). They have different mechanisms, dose schedules and side-effect profiles. Suitability is a clinical decision for a UK-registered prescriber.
Which is more effective for weight management?
Pivotal trial data (SURMOUNT-1 for tirzepatide, STEP-1 for semaglutide 2.4mg) reported mean percentage body-weight reduction in the order of around 21% for tirzepatide 15mg and around 15% for semaglutide 2.4mg over 68–72 weeks. Trial endpoints are population averages; individual response varies by dose, adherence and other factors. Discuss the most relevant evidence with a UK-registered prescriber.
Why does this comparison not show prices?
Mounjaro and Wegovy are prescription-only medicines (POMs) in the UK. UK Human Medicines Regulations 2012 prohibit advertising POMs to the public, including price comparisons. TreatCompare therefore does not display UK Mounjaro or Wegovy prices.
Get an email when prices change
Free alerts when a new provider lists, or the lower-cost published price falls. Confirm by email; unsubscribe in one click.
We'll send a confirmation link first. No marketing — alerts only. Unsubscribe with one click in any email.
Compare prices from verified providers
Weight Loss Injection Prices
Compare Mounjaro, Wegovy, Ozempic, and Nevolat prices from verified GPhC-registered UK pharmacies. Checked weekly.
Related articles
GLP-1 Weight-Management Medicines in the UK: Patient Information (2026)
Patient information about the GLP-1 receptor agonists used for weight management or type 2 diabetes in the UK — Mounjaro, Wegovy, Ozempic, Rybelsus, Nevolat. No prescription-medicine prices.
How to Get Mounjaro in the UK: Patient Information (2026)
Patient information about UK NHS and private routes for Mounjaro (tirzepatide). Not an advertisement and not medical advice.
Mounjaro in the UK: Patient Information
General patient information about Mounjaro (tirzepatide) in the UK and the service-level cost components of a UK private weight-management consultation. Not an advertisement and not medical advice.
Mounjaro Maintenance Dose in the UK: Patient Information
General patient information about the Mounjaro (tirzepatide) maintenance-dose phase in the UK. Not an advertisement and not medical advice.